Evidence map›Paper›PMID 41455958›Full record

ArticleWorld journal of surgical oncology2025

Malignant rhabdoid tumor of the kidney in a 27-Year-Old adult: a rare case with favorable outcomes following surgery and adjuvant radiotherapy.

Dimitri Paillusson, Stéphane De Vergie, Jérome Rigaud, Gaëlle Le Quellennec, Stéphane Supiot

Abstract readCase Reports
In one paragraph

Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dimitri PaillussonDepartment of Urology, CHU de Nantes, 1 place Alexis Ricordeau, Nantes, France. dimitri.paillusson@chu-nantes.fr.
Stéphane De VergieDepartment of Urology, CHU de Nantes, 1 place Alexis Ricordeau, Nantes, France.
Jérome RigaudDepartment of Urology, CHU de Nantes, 1 place Alexis Ricordeau, Nantes, France.
Gaëlle Le QuellennecDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, France.
Stéphane SupiotDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalignant rhabdoid tumors of the kidney are exceptionally rare in adults and typically occur in children under 2 years of age. This case report outlines the diagnosis, treatment, and outcome of an adult patient with renal malignant rhabdoid tumors. CASE PRESENTATION: A 27-year-old man presented with febrile urinary tract infection and reported intermittent hematuria for six months. Imaging revealed a left renal mass initially misdiagnosed as an abscess. Tumor progression was later confirmed, and biopsy identified an malignant rhabdoid tumors, characterized by the loss of INI-1 nuclear protein expression and homozygous deletion of the SMARCB1 gene. Radical nephrectomy was performed, followed by adjuvant radiotherapy (36 Gy in 20 fractions), on the basis of pediatric protocols. The tumor was staged as pT3a N0 R0, with no extrarenal extension or metastases. No significant radiotherapy-related toxicity was observed. OUTCOME: After five years of follow-up with alternating CT and MRI, the patient remained free of recurrence or metastasis. Postoperative renal function was stable despite the nephrectomy and radiotherapy.

conclusionThis case adds to the limited number of reported adult renal malignant rhabdoid tumors. Early diagnosis, complete surgical resection, and adjuvant radiotherapy may contribute to long-term remission. Pediatric treatment guidelines may be valuable in managing these rare adult cases.

Indexed as

Kidney NeoplasmsNephrectomyRhabdoid TumorAdultCombined Modality TherapyHumansMalePrognosisRadiotherapy, AdjuvantSMARCB1 ProteinTomography, X-Ray ComputedSMARCB1 ProteinSMARCB1 protein, humanKidney MRTMalignant rhabdoid tumorRare kidney tumor

Identifiers

PMID41455958
PMCPMC12853882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.